Development of Molecularly Targeted Therapies to Treat Pediatric Malignancies

Drugs and biologics developed to treat children with cancer have been historically developed in adults for adult indications. Although leading to many useful drugs and biologics to treat pediatric cancer, future development of molecularly targeted therapies (MTTs) should be directed toward pediatric...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, Clinton F., Robinson, Giles W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Development
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656826/
https://www.ncbi.nlm.nih.gov/pubmed/28836264
http://dx.doi.org/10.1002/cpt.785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656826/
https://www.ncbi.nlm.nih.gov/pubmed/28836264
http://dx.doi.org/10.1002/cpt.785

Ejemplares similares